Sign In
Buy TECH
$56.26
+0.650 (+1.17%)
At Close: Jun 23, 2026
Bio-Techne Q4 Preview: NIH Funding Cut And Tariffs Impacts, Initiate At Sell
01:19pm, Monday, 28'th Jul 2025
Bio-Techne Corporation is a market leader in life science reagents, well positioned for long-term growth in cell and gene therapeutics and organoid solutions. Despite strong fundamentals and recurring
CMB.TECH's update on the Golden Ocean merger process
04:43pm, Thursday, 17'th Jul 2025
Antwerp, July 17, 2025 (GLOBE NEWSWIRE) -- CMB.TECH NV (NYSE: CMBT & Euronext Brussels: CMBT) (“CMB.TECH”) provides a market update on the progress of the stock-for-stock merger between CMB.TECH a
Bio-Techne to Host Conference Call on August 6, 2025, to Announce Fourth Quarter and Fiscal 2025 Financial Results
07:00am, Thursday, 17'th Jul 2025
MINNEAPOLIS , July 17, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday, August 6, 2025, at 8:00 a.m. CDT
INCY or TECH: Which Is the Better Value Stock Right Now?
12:41pm, Wednesday, 16'th Jul 2025
Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider either Incyte (INCY) or Techne (TECH). But which of these two stocks is more attractive to value inv
American Trust Investment Services Serves as Sole Underwriter for K-TECH Solutions Co., Ltd. IPO
11:23am, Wednesday, 16'th Jul 2025
Firm Expands Leadership in Capital Markets with Successful Nasdaq IPO Execution NEW YORK , July 16, 2025 /PRNewswire/ -- American Trust Investment Services, Inc. (ATIS) today announced the successful
Spear Bio Announces Strategic Partnership with Bio-Techne to Accelerate the Deployment of Its Next-Generation Immunoassay Technology
09:03am, Tuesday, 15'th Jul 2025
WOBURN, Mass.--(BUSINESS WIRE)--Spear Bio, a biotechnology company pioneering homogeneous ultrasensitive immunoassay technology, is pleased to announce a strategic distribution partnership with Bio-Te
Bio-Techne and Spear Bio Announce Strategic Partnership to Advance Therapeutic Development with Ultrasensitive Biomarker Detection
07:00am, Tuesday, 15'th Jul 2025
MINNEAPOLIS , July 15, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced a strategic partnership to distribute Spear Bio's next-generation ultrasensitive immunoassays, enablin
Bio-Techne's Simple Western™ Technology Utilized in Recent FDA Approval of ZEVASKYN™ Cell-Based Gene Therapy
07:00am, Monday, 14'th Jul 2025
MINNEAPOLIS , July 14, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that its Simple Western™ Technology played a key role in supporting the FDA approval of ZEVASKYN™
Bio-Techne's New USP Deal on mAb and Gene Therapy May Boost Its Stock
09:50am, Monday, 30'th Jun 2025
TECH teams up with USP to boost mAb and gene therapy testing, aiming to simplify analytics and enhance product quality.
Bio-Techne and USP Announce Collaboration to Accelerate Monoclonal Antibody and Gene Therapy Product Development
07:00am, Tuesday, 24'th Jun 2025
MINNEAPOLIS , June 24, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced a distribution agreement with the U.S. Pharmacopeia (USP) that enables the Company to sell USP monoclo
ScaleReady Announces a G-Rex® Grant has been awarded to Immuneel Therapeutics
07:00am, Tuesday, 10'th Jun 2025
ST. PAUL, Minn. , June 10, 2025 /PRNewswire/ -- ScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation and CellReady, today announced that Immuneel Therapeutics has been a
Why Is Techne (TECH) Down 3% Since Last Earnings Report?
12:36pm, Friday, 06'th Jun 2025
Techne (TECH) reported earnings 30 days ago. What's next for the stock?
Is Bio-Techne Stock the Right Pick for Your Portfolio Now?
09:50am, Thursday, 29'th May 2025
Bio-Techne's TECH GMP reagents, including GMP proteins and small molecules, remain a cornerstone of its cell therapy offering. Acquisitions have continued to play an important role in the company's ef
Bio-Techne to Present at Investor Conferences
07:00am, Thursday, 29'th May 2025
MINNEAPOLIS , May 29, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that it will present at the following investor conferences: William Blair 45th Annual Growth Stock Conf
CMB.TECH NV AND GOLDEN OCEAN GROUP LIMITED ANNOUNCE AGREEMENT AND PLAN OF MERGER
04:51pm, Wednesday, 28'th May 2025
Antwerp, May 28, 2025 (GLOBE NEWSWIRE) -- CMB.TECH NV AND GOLDEN OCEAN GROUP LIMITED ANNOUNCE AGREEMENT AND PLAN OF MERGER CMB.TECH NV (NYSE: CMBT & Euronext Brussels: CMBT) (“CMB.TECH”) and Golde
